Abstract B159: Phase I dose-escalation study of BKM120, an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors.

2011 ◽  
Author(s):  
Toshihiko Doi ◽  
Yuichi Ando ◽  
Hideaki Bando ◽  
Takayuki Yoshino ◽  
Megumi Inada ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study

scholarly journals Phase I dose‐escalation study of buparlisib ( BKM 120), an oral pan‐class I PI 3K inhibitor, in Japanese patients with advanced solid tumors

2014 ◽  
Vol 105 (3) ◽  
pp. 347-353 ◽  
Author(s):  
Yuichi Ando ◽  
Megumi Inada‐Inoue ◽  
Ayako Mitsuma ◽  
Takayuki Yoshino ◽  
Atsushi Ohtsu ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Class I ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study

scholarly journals Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors

2017 ◽  
Vol 7 (7) ◽  
pp. 704-715 ◽  
Author(s):  
Dejan Juric ◽  
Ian Krop ◽  
Ramesh K. Ramanathan ◽  
Timothy R. Wilson ◽  
Joseph A. Ware ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Pi3k Inhibitor ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study

scholarly journals Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147), a Pan‐Class I PI3K Inhibitor, in Combination With Erlotinib in Patients With Solid Tumors

2015 ◽  
Vol 20 (3) ◽  
pp. 245-246 ◽  
Author(s):  
Jean‐Charles Soria ◽  
Patricia LoRusso ◽  
Ratislav Bahleda ◽  
Joanne Lager ◽  
Li Liu ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Dose Escalation Study

scholarly journals Phase I dose‐escalation study of capmatinib ( INC 280) in Japanese patients with advanced solid tumors

2019 ◽  
Vol 110 (4) ◽  
pp. 1340-1351 ◽  
Author(s):  
Taito Esaki ◽  
Fumihiko Hirai ◽  
Akitaka Makiyama ◽  
Takashi Seto ◽  
Hideaki Bando ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

2014 ◽  
Vol 32 (4) ◽  
pp. 670-681 ◽  
Author(s):  
Jordi Rodon ◽  
Irene Braña ◽  
Lillian L Siu ◽  
Maja J De Jonge ◽  
Natasha Homji ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors

scholarly journals Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

2014 ◽  
Vol 74 (3) ◽  
pp. 629-636 ◽  
Author(s):  
Toshihiko Doi ◽  
Yusuke Onozawa ◽  
Nozomu Fuse ◽  
Takayuki Yoshino ◽  
Kentaro Yamazaki ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Hsp90 Inhibitor ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study
Sign in / Sign up

Export Citation Format

Share Document